<p>随着美国股市在与中国的贸易紧张局势中波动，主要指数出现显著的周度损失，投资者越来越关注小型股，认为它们在更广泛的市场波动中可能提供机会。在这种情况下，识别有前景的小型公司至关重要，因为这些常被忽视的 “宝石” 可能在经济不确定性中提供独特的增长前景和韧性。</p>
<h3>美国十大未被发现的基本面强劲的宝藏股</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>债务股本比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>南密歇根银行控股公司</td>
<td>117.38%</td>
<td>8.87%</td>
<td>4.89%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Senstar Technologies</td>
<td>NA</td>
<td>-18.50%</td>
<td>29.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Metalpha Technology Holding</td>
<td>NA</td>
<td>75.66%</td>
<td>28.60%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>First Northern Community Bancorp</td>
<td>NA</td>
<td>8.05%</td>
<td>12.27%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>FineMark Holdings</td>
<td>115.37%</td>
<td>2.22%</td>
<td>-28.34%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Valhi</td>
<td>44.30%</td>
<td>1.10%</td>
<td>-1.40%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>NameSilo Technologies</td>
<td>14.73%</td>
<td>14.50%</td>
<td>-1.32%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Pure Cycle</td>
<td>5.02%</td>
<td>4.35%</td>
<td>-2.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Linkhome Holdings</td>
<td>7.03%</td>
<td>215.05%</td>
<td>239.56%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Greenfire Resources</td>
<td>35.48%</td>
<td>-1.31%</td>
<td>-25.79%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国基本面强劲的未被发现的宝藏股筛选器中的 291 只股票的完整列表。</p>
<p>我们将从我们的筛选结果中选取一些进行分析。</p>
<h2>Power Solutions International (PSIX)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Power Solutions International, Inc. 设计、工程、制造、营销和销售发动机及电力系统，全球市值约为 19.7 亿美元。</p>
<p><strong>运营：</strong> PSIX 的收入主要来自其工程集成电力发电系统，金额为 5.9749 亿美元。公司的财务表现受到其成本结构和市场动态的影响。</p>
<p>Power Solutions International (PSI) 在过去一年中实现了 147.5% 的令人瞩目的盈利增长，超越了电气行业的 7.5%。公司还在五年内将其债务股本比显著降低，从 1259.1% 降至令人满意的 72.1%，表明财务健康状况改善。PSI 的市盈率为 17.8 倍，相较于美国市场的平均市盈率 18.5 倍，具有良好的价值。最近的战略举措包括与 HD Hyundai Infracore 签署新协议，并通过修订信贷协议将借款能力提高至 1.35 亿美元，增强了财务灵活性和增长潜力。</p>
<ul>
<li>在我们的健康报告中更详细地了解 Power Solutions International 的潜力。</li>
<li>通过查看我们的历史报告了解 Power Solutions International 的业绩记录。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 10 月 PSIX 的债务股本比</p>
<h2>Puma Biotechnology (PBYI)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Puma Biotechnology, Inc. 是一家生物制药公司，开发和商业化产品以提升美国及国际的癌症护理，市值为 2.579 亿美元。</p>
<p><strong>运营：</strong> Puma Biotechnology 从其癌症护理产品中获得 2.3806 亿美元的收入。公司的净利润率趋势提供了其财务表现的洞察。</p>
<p>Puma Biotechnology 在癌症护理领域表现出色，过去一年盈利增长达到 455.6%，超越了同行。其交易价格低于估计公允价值的 76.2%，且在五年内将债务股本比从 412.7% 降至 42.8%，尽管面临挑战，但仍呈现出引人注目的投资案例。公司在 2025 年第二季度报告了 5200 万美元的收入，并从去年的亏损中转为 586 万美元的净收入，但由于成本上升和对 NERLYNX 销售的依赖，未来盈利预计将平均下降 34.1%。</p>
<ul>
<li>Puma Biotechnology 对 NERLYNX 的依赖在入组和特许权使用费收入下降的情况下挑战了其增长。点击这里探索 Puma Biotechnology 的战略前景的完整叙述。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 10 月 PBYI 的债务股本比</p>
<h2>Idaho Strategic Resources (IDR)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Idaho Strategic Resources, Inc. 是一家资源型公司，专注于在北爱达荷州探索、开发和提取黄金、白银和基础金属矿产资源，市值为 6.3606 亿美元。</p>
<p><strong>运营：</strong> 公司的收入为 3050 万美元，来源于探索和开发黄金、白银和基础金属矿产资源。</p>
<p>Idaho Strategic Resources 在过去一年中展现出 74% 的盈利增长，显著超越了金属和矿业行业。公司在五年内将债务股本比从 29.2% 降至 6.3%，表明财务管理强劲。最近的盈利报告显示，第二季度净收入为 277 万美元，较去年增加了 216 万美元。尽管股价波动，Idaho Strategic 仍保持盈利，拥有足够的现金覆盖债务，并已被纳入 S&amp;P/TSX 全球矿业指数。</p>
<ul>
<li>点击这里通过我们的详细分析健康报告发现 Idaho Strategic Resources 的细微差别。</li>
<li>查看我们的历史业绩报告，以获取对 Idaho Strategic Resources 过去表现的洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 10 月 IDR 的债务股本比</p>
<h2>接下来该如何做？</h2>
<ul>
<li>在这里浏览 291 只具有强大基本面的美国未被发现的优质股票的完整清单。</li>
<li>已经拥有这些公司？通过将您的投资组合与 Simply Wall St 连接，清晰化您的投资决策，您可以轻松监控所有股票的关键指标。</li>
<li>Simply Wall St 是一款为长期股票投资者设计的革命性应用程序，免费且覆盖全球所有市场。</li>
</ul>
<h2>考虑其他策略？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章性质一般。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

PSIX

<p>随着美国股市面临与中国的贸易紧张局势，投资者正将目光转向小型股以寻找潜在机会。值得注意的小型公司包括 Power Solutions International、Puma Biotechnology 和 Idaho Strategic Resources，这些公司都显示出令人印象深刻的盈利增长和改善的财务健康状况。Power Solutions International 的市值为 19.7 亿美元，盈利增长达 147.5%。Puma Biotechnology 的估值为 2.579 亿美元，盈利增长达到 455.6%。Idaho Strategic Resources 的市值为 6.3606 亿美元，报告的盈利增长为 74%。在市场波动中，这些公司代表了有前景的投资机会</p>

<p>As the U.S. stock market navigates renewed trade tensions with China, resulting in significant weekly losses for major indices, investors are increasingly turning their attention to small-cap stocks as potential opportunities amidst broader market volatility. In this climate, identifying promising small-cap companies can be crucial, as these often-overlooked gems may offer unique growth prospects and resilience despite economic uncertainties.</p>
<div class="lb-trans"><p>随着美国股市在与中国的贸易紧张局势中波动，主要指数出现显著的周度损失，投资者越来越关注小型股，认为它们在更广泛的市场波动中可能提供机会。在这种情况下，识别有前景的小型公司至关重要，因为这些常被忽视的 “宝石” 可能在经济不确定性中提供独特的增长前景和韧性。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals In The United States</h3>
<div class="lb-trans"><h3>美国十大未被发现的基本面强劲的宝藏股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Southern Michigan Bancorp</td>
<td>117.38%</td>
<td>8.87%</td>
<td>4.89%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Senstar Technologies</td>
<td>NA</td>
<td>-18.50%</td>
<td>29.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Metalpha Technology Holding</td>
<td>NA</td>
<td>75.66%</td>
<td>28.60%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>First Northern Community Bancorp</td>
<td>NA</td>
<td>8.05%</td>
<td>12.27%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>FineMark Holdings</td>
<td>115.37%</td>
<td>2.22%</td>
<td>-28.34%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Valhi</td>
<td>44.30%</td>
<td>1.10%</td>
<td>-1.40%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>NameSilo Technologies</td>
<td>14.73%</td>
<td>14.50%</td>
<td>-1.32%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Pure Cycle</td>
<td>5.02%</td>
<td>4.35%</td>
<td>-2.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Linkhome Holdings</td>
<td>7.03%</td>
<td>215.05%</td>
<td>239.56%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Greenfire Resources</td>
<td>35.48%</td>
<td>-1.31%</td>
<td>-25.79%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>债务股本比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>南密歇根银行控股公司</td>
<td>117.38%</td>
<td>8.87%</td>
<td>4.89%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Senstar Technologies</td>
<td>NA</td>
<td>-18.50%</td>
<td>29.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Metalpha Technology Holding</td>
<td>NA</td>
<td>75.66%</td>
<td>28.60%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>First Northern Community Bancorp</td>
<td>NA</td>
<td>8.05%</td>
<td>12.27%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>FineMark Holdings</td>
<td>115.37%</td>
<td>2.22%</td>
<td>-28.34%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Valhi</td>
<td>44.30%</td>
<td>1.10%</td>
<td>-1.40%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>NameSilo Technologies</td>
<td>14.73%</td>
<td>14.50%</td>
<td>-1.32%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Pure Cycle</td>
<td>5.02%</td>
<td>4.35%</td>
<td>-2.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Linkhome Holdings</td>
<td>7.03%</td>
<td>215.05%</td>
<td>239.56%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Greenfire Resources</td>
<td>35.48%</td>
<td>-1.31%</td>
<td>-25.79%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 291 stocks from our US Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国基本面强劲的未被发现的宝藏股筛选器中的 291 只股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我们将从我们的筛选结果中选取一些进行分析。</p>
</div><h2>Power Solutions International (PSIX)</h2>
<div class="lb-trans"><h2>Power Solutions International (PSIX)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Power Solutions International, Inc. designs, engineers, manufactures, markets, and sells engines and power systems globally with a market cap of approximately $1.97 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Power Solutions International, Inc. 设计、工程、制造、营销和销售发动机及电力系统，全球市值约为 19.7 亿美元。</p>
</div><p><strong>Operations:</strong> PSIX generates revenue primarily from its Engineered Integrated Electrical Power Generation Systems, amounting to $597.49 million. The company's financial performance is influenced by its cost structure and market dynamics.</p>
<div class="lb-trans"><p><strong>运营：</strong> PSIX 的收入主要来自其工程集成电力发电系统，金额为 5.9749 亿美元。公司的财务表现受到其成本结构和市场动态的影响。</p>
</div><p>Power Solutions International (PSI) has been making waves with its impressive earnings growth of 147.5% over the past year, outpacing the Electrical industry's 7.5%. The company has also reduced its debt to equity ratio significantly from 1259.1% to a satisfactory 72.1% over five years, indicating improved financial health. Trading at a price-to-earnings ratio of 17.8x, PSI is considered good value compared to the US market's average of 18.5x. Recent strategic moves include a new agreement with HD Hyundai Infracore and an increase in borrowing capacity to $135 million through an amended credit agreement, enhancing financial flexibility and growth potential.</p>
<div class="lb-trans"><p>Power Solutions International (PSI) 在过去一年中实现了 147.5% 的令人瞩目的盈利增长，超越了电气行业的 7.5%。公司还在五年内将其债务股本比显著降低，从 1259.1% 降至令人满意的 72.1%，表明财务健康状况改善。PSI 的市盈率为 17.8 倍，相较于美国市场的平均市盈率 18.5 倍，具有良好的价值。最近的战略举措包括与 HD Hyundai Infracore 签署新协议，并通过修订信贷协议将借款能力提高至 1.35 亿美元，增强了财务灵活性和增长潜力。</p>
</div><ul>
<li>Take a closer look at Power Solutions International's potential here in our health report.</li>
<li>Understand Power Solutions International's track record by examining our Past report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的健康报告中更详细地了解 Power Solutions International 的潜力。</li>
<li>通过查看我们的历史报告了解 Power Solutions International 的业绩记录。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis"/></p>
<p>PSIX Debt to Equity as at Oct 2025</p>
<div class="lb-trans"><p>截至 2025 年 10 月 PSIX 的债务股本比</p>
</div><h2>Puma Biotechnology (PBYI)</h2>
<div class="lb-trans"><h2>Puma Biotechnology (PBYI)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Puma Biotechnology, Inc. is a biopharmaceutical company that develops and commercializes products to enhance cancer care both in the United States and internationally, with a market cap of $257.90 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Puma Biotechnology, Inc. 是一家生物制药公司，开发和商业化产品以提升美国及国际的癌症护理，市值为 2.579 亿美元。</p>
</div><p><strong>Operations:</strong> Puma Biotechnology generates revenue of $238.06 million from its cancer care products. The company's net profit margin trends provide insights into its financial performance.</p>
<div class="lb-trans"><p><strong>运营：</strong> Puma Biotechnology 从其癌症护理产品中获得 2.3806 亿美元的收入。公司的净利润率趋势提供了其财务表现的洞察。</p>
</div><p>Puma Biotechnology, a player in the cancer care sector, has shown impressive earnings growth of 455.6% over the past year, outpacing its industry peers. Trading at 76.2% below its estimated fair value and with a debt-to-equity ratio reduced from 412.7% to 42.8% in five years, it presents an intriguing investment case despite challenges ahead. The company reported US$52 million in Q2 revenue for 2025 and turned a net income of US$5.86 million from a loss last year, but faces future earnings decline forecasts averaging 34.1% annually due to rising costs and reliance on NERLYNX sales alone.</p>
<div class="lb-trans"><p>Puma Biotechnology 在癌症护理领域表现出色，过去一年盈利增长达到 455.6%，超越了同行。其交易价格低于估计公允价值的 76.2%，且在五年内将债务股本比从 412.7% 降至 42.8%，尽管面临挑战，但仍呈现出引人注目的投资案例。公司在 2025 年第二季度报告了 5200 万美元的收入，并从去年的亏损中转为 586 万美元的净收入，但由于成本上升和对 NERLYNX 销售的依赖，未来盈利预计将平均下降 34.1%。</p>
</div><ul>
<li>Puma Biotechnology's reliance on NERLYNX amid declining enrollments and royalty revenues challenges growth. Click here to explore the full narrative on Puma Biotechnology's strategic outlook.</li>
</ul>
<div class="lb-trans"><ul>
<li>Puma Biotechnology 对 NERLYNX 的依赖在入组和特许权使用费收入下降的情况下挑战了其增长。点击这里探索 Puma Biotechnology 的战略前景的完整叙述。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis"/></p>
<p>PBYI Debt to Equity as at Oct 2025</p>
<div class="lb-trans"><p>截至 2025 年 10 月 PBYI 的债务股本比</p>
</div><h2>Idaho Strategic Resources (IDR)</h2>
<div class="lb-trans"><h2>Idaho Strategic Resources (IDR)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Idaho Strategic Resources, Inc. is a resource-based company focused on the exploration, development, and extraction of gold, silver, and base metal mineral resources in North Idaho with a market cap of $636.06 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Idaho Strategic Resources, Inc. 是一家资源型公司，专注于在北爱达荷州探索、开发和提取黄金、白银和基础金属矿产资源，市值为 6.3606 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue of $30.50 million is derived from exploring and developing gold, silver, and base metal mineral resources.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入为 3050 万美元，来源于探索和开发黄金、白银和基础金属矿产资源。</p>
</div><p>Idaho Strategic Resources has been making waves with its impressive financial performance, showcasing a 74% earnings growth over the past year, significantly outpacing the Metals and Mining industry. The company has managed to reduce its debt-to-equity ratio from 29.2% to 6.3% over five years, indicating strong financial management. Recent earnings reports reveal a net income of US$2.77 million for the second quarter, up from US$2.16 million the previous year. Despite a volatile share price, Idaho Strategic remains profitable, with sufficient cash to cover its debts, and has been added to the S&amp;P/TSX Global Mining Index.</p>
<div class="lb-trans"><p>Idaho Strategic Resources 在过去一年中展现出 74% 的盈利增长，显著超越了金属和矿业行业。公司在五年内将债务股本比从 29.2% 降至 6.3%，表明财务管理强劲。最近的盈利报告显示，第二季度净收入为 277 万美元，较去年增加了 216 万美元。尽管股价波动，Idaho Strategic 仍保持盈利，拥有足够的现金覆盖债务，并已被纳入 S&amp;P/TSX 全球矿业指数。</p>
</div><ul>
<li>Click here to discover the nuances of Idaho Strategic Resources with our detailed analytical health report.</li>
<li>Review our historical performance report to gain insights into Idaho Strategic Resources''s past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里通过我们的详细分析健康报告发现 Idaho Strategic Resources 的细微差别。</li>
<li>查看我们的历史业绩报告，以获取对 Idaho Strategic Resources 过去表现的洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis"/></p>
<p>IDR Debt to Equity as at Oct 2025</p>
<div class="lb-trans"><p>截至 2025 年 10 月 IDR 的债务股本比</p>
</div><h2>Where To Now?</h2>
<div class="lb-trans"><h2>接下来该如何做？</h2>
</div><ul>
<li>Navigate through the entire inventory of 291 US Undiscovered Gems With Strong Fundamentals here.</li>
<li>Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.</li>
<li>Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里浏览 291 只具有强大基本面的美国未被发现的优质股票的完整清单。</li>
<li>已经拥有这些公司？通过将您的投资组合与 Simply Wall St 连接，清晰化您的投资决策，您可以轻松监控所有股票的关键指标。</li>
<li>Simply Wall St 是一款为长期股票投资者设计的革命性应用程序，免费且覆盖全球所有市场。</li>
</ul>
</div><h2>Contemplating Other Strategies?</h2>
<div class="lb-trans"><h2>考虑其他策略？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章性质一般。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

美国市场中的未被发现的宝石，介绍三只有前景的小盘股